Paragon Capital Management Ltd Lowers Stock Position in Colgate-Palmolive Company $CL

Paragon Capital Management Ltd lessened its holdings in Colgate-Palmolive Company (NYSE:CL) by 15.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,076 shares of the company’s stock after selling 718 shares during the quarter. Paragon Capital Management Ltd’s holdings in Colgate-Palmolive were worth $371,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in CL. Brighton Jones LLC boosted its holdings in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in Colgate-Palmolive by 4.5% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 266,407 shares of the company’s stock valued at $24,219,000 after purchasing an additional 11,484 shares in the last quarter. 111 Capital purchased a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $377,000. MassMutual Private Wealth & Trust FSB boosted its holdings in Colgate-Palmolive by 42.5% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 5,965 shares of the company’s stock valued at $559,000 after purchasing an additional 1,778 shares in the last quarter. Finally, Versant Capital Management Inc boosted its holdings in Colgate-Palmolive by 222.2% in the 1st quarter. Versant Capital Management Inc now owns 6,060 shares of the company’s stock valued at $568,000 after purchasing an additional 4,179 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.2%

Shares of Colgate-Palmolive stock opened at $79.57 on Friday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a 1 year low of $78.76 and a 1 year high of $104.16. The company has a market capitalization of $64.31 billion, a P/E ratio of 22.35, a P/E/G ratio of 4.14 and a beta of 0.35. The business has a 50 day moving average price of $84.19 and a 200 day moving average price of $88.71.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the previous year, the firm posted $0.91 EPS. The company’s quarterly revenue was up 1.0% compared to the same quarter last year. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s payout ratio is currently 58.43%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on CL shares. Morgan Stanley lowered their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Barclays boosted their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 15th. UBS Group decreased their price target on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a research note on Thursday, July 17th. Finally, Citigroup decreased their price target on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $97.73.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.